Serum Angiopoietin-like Protein 6, Risk of Type 2 Diabetes, and Response to Hyperglycemia: A Prospective Cohort Study
Journal
The Journal of clinical endocrinology and metabolism
Journal Volume
105
Journal Issue
5
Date Issued
2020-05-01
Author(s)
Wu, Hung-Tsung
Wei, Jung-Nan
Hsu, Chih-Yao
Lin, Chia-Hung
Abstract
Angiopoietin-like protein 6 (ANGPTL6) is a hepatokine that improves insulin sensitivity in animals. However, serum ANGPTL6 concentration was found to be higher in human participants with diabetes or metabolic syndrome in cross-sectional studies, implying that ANGPTL6 may be induced to counteract hyperglycemia.
Subjects
angiopoietin-like protein 6; biomarker; diabetes; hyperglycemia
SDGs
Publisher
ENDOCRINE SOC
Type
journal article